Emerging biological roles for erythropoietin in the nervous system
The DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Erythropoietin mediates an evolutionarily conserved, ancient immune response that limits damage to the heart, the nervous system and other tissues following injury. New evidence indicates that erythropoietin specifically prevents the destruction of viable tissue surrounding the site of an injury by signalling through a non-haematopoietic receptor. Engineered derivatives of erythropoietin that have a high affinity for this receptor have been developed, and these show robust tissue-protective effects in diverse preclinical models without stimulating erythropoiesis. A recent successful proof-of-concept clinical trial that used erythropoietin to treat human patients who had suffered a stroke encourages the evaluation of both this cytokine and non-erythropoietic derivatives as therapeutic agents to limit tissue injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Erythropoietin was originally recognized via its role in erythropoiesis [2145-2147] (hence its name, of course), but it has become evident that it has many other roles, and in particular it is observed phenomenologically that erythropoietin (and non-erthyropoetic derivatives) is protective in a number of inflammatory conditions that accompany many diseases such as those listed above [940,942,2148-”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [2150]
Citations
Cites
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
Brines, M. L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N. C., Cerami, C., Itri, L. M., & Cerami, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10526 · Cited by 1,402 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundSelf-citationHIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Henke, M., Laszig, R., Rübe, C., Schäfer, U., Haase, K.-D., Schilcher, B., Mose, S., Beer, K. T., Burger, U., Dougherty, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14567-9 · Cited by 1,250 · cited 1×
“It is worrying that some cancer patients treated with rhEPO have also shown tumour expansio”
BackgroundErythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.-H., Breiter, N., Jacob, S., Knerlich, F., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402029 · Cited by 1,028
Self-citationJuhaszova, M., Zorov, D. B., Kim, S.-H., Pepe, S., Fu, Q., Fishbein, K. W., Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19906 · Cited by 1,026
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Self-citationIn vivo evidence that erythropoietin protects neurons from ischemic damage
Sakanaka, M., Wen, T.-C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., & Sasaki, R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4635 · Cited by 949 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundDigicaylioglu, M., & Lipton, S. A. (2001) · Nature · doi:10.1038/35088074 · Cited by 923 · cited 1×
“Furthermore, although it has been reported that STAT is part of erythropoietin's neuroprotective signalling cascade in vitro , in vivo studies largely have not supported the involvement of STATs in erythropoietin cytoprotectio”
BackgroundPurification of human erythropoietin.
Miyake, T., Kung, C. K., & Goldwasser, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)63387-9 · Cited by 886
Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., et al. (2004) · Science · doi:10.1126/science.1098313 · Cited by 803
Self-citationIschemic tolerance and endogenous neuroprotection
Dirnagl, U., Simon, R. P., & Hallenbeck, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00071-7 · Cited by 791 · cited 1×
“However, ischaemic preconditioning in the heart and the brain occurs in two phases: an early phase, mediated by potassium channel activation, that lasts only a few hours, and a delayed phase, requiring gene expression, that develops slowly over 12–24 h and persists for several days (for reviews, see Ref”
BackgroundWang, L., Zhang, Z., Wang, Y., Zhang, R., & Chopp, M. (2004) · Stroke · doi:10.1161/01.str.0000132196.49028.a4 · Cited by 763 · cited 1×
“Moreover, erythropoietin can also act synergistically with VEGF to stimulate angiogenesis after injur”
BackgroundA Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in Mice
Bernaudin, M., Marti, H. H., Roussel, S., Divoux, D., Nouvelot, A., MacKenzie, E. T., & Petit, E. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199906000-00007 · Cited by 715
Erythropoietin: Physiology and Pharmacology Update
Fisher, J. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800101 · Cited by 708
Morishita, E., Masuda, S., Nagao, M., Yasuda, Y., & Sasaki, R. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)00306-5 · Cited by 661 · cited 1×
“Follow-up studies confirmed erythropoietin to be a neuroprotective factor in hypoxic-ischaemic, traumatic, excitotoxic and inflammatory injurie”
BackgroundBrines, M., Grasso, G., Fiordaliso, F., Sfacteria, A., Ghezzi, P., Fratelli, M., Latini, R., Xie, Q.-W., Smart, J., Su-Rick, C.-J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406491101 · Cited by 656 · cited 1×
“Recently, we postulated that a receptor distinct from those expressed by erythroid precursors specifically mediates tissue protectio”
BackgroundSelf-citationShingo, T., Sorokan, S. T., Shimazaki, T., & Weiss, S. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09733.2001 · Cited by 653 · cited 1×
“, and that it might function in neurogenesis and in guiding stem cells into damaged tissues in adult”
BackgroundCrystallographic Evidence for Preformed Dimers of Erythropoietin Receptor Before Ligand Activation
Livnah, O., Stura, E. A., Middleton, S. A., Johnson, D. L., Jolliffe, L. K., & Wilson, I. A. (1999) · Science · doi:10.1126/science.283.5404.987 · Cited by 599 · cited 1×
“The erythroid receptor exists as a preformed EPOR homodime”
BackgroundErythropoietin has a mitogenic and positive chemotactic effect on endothelial cells.
Anagnostou, A., Lee, E. S., Kessimian, N., Levinson, R., & Steiner, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5978 · Cited by 569 · cited 1×
“The first suggestion that erythropoietin might have an additional biological activity resulted from a chance observation by Anagnostou and co-worker”
BackgroundLongitudinal study of brain morphology in first episode schizophrenia
Lieberman, J., Chakos, M., Wu, H., Alvir, J., Hoffman, E., Robinson, D., & Bilder, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01067-8 · Cited by 554 · cited 1×
“The brain pathology of patients with schizophrenia indicates that there is a neurotoxic component in this diseas”
BackgroundVilla, P., Bigini, P., Mennini, T., Agnello, D., Laragione, T., Cagnotto, A., Viviani, B., Marinovich, M., Cerami, A., Coleman, T. R., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021067 · Cited by 527 · cited 1×
“Notably, erythropoietin suppresses the inflammatory mononuclear cell infiltration and the burst of pro-inflammatory cytokines in an animal model of stroke with reperfusio”
BackgroundSelf-citationGrimm, C., Wenzel, A., Groszer, M., Mayser, H., Seeliger, M., Samardzija, M., Bauer, C., Gassmann, M., & Remé, C. E. (2002) · Nature Medicine · doi:10.1038/nm723 · Cited by 518 · cited 1×
“Systemically administered erythropoietin can also cross other tissues with tight endothelial barriers, including the retin”
BackgroundNagelhus, E. A., Mathiisen, T. M., & Ottersen, O. P. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.053 · Cited by 511 · cited 1×
“It is intriguing that the tissue distribution of EPOR is similar to that of aquaporin 4, the brain isoform of the water-transporting proteins in the astrocytic end-feet that surround capillaries, the choroid plexus and ependymal cell”
Breast cancer trial with erythropoietin terminated unexpectedly
Leyland-Jones, B. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01163-x · Cited by 474 · cited 1×
“For example, the use of erythropoietin to keep the haematocrit (the ratio of the volume of erythrocytes to the total volume of blood) within the normal range has shown that these prophetic adverse effects are real and problemati”
MethodCelik, M., Gökmen, N., Erbayraktar, S., Akhisaroglu, M., Konakç, S., Ulukus, C., Genc, S., Genc, K., Sagiroglu, E., Cerami, A., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042693799 · Cited by 473 · cited 1×
“Studies using other injury models, such as ischaemia of the spinal cor”
MethodSelf-citationA novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes.
Masuda, S., Okano, M., Yamagishi, K., Nagao, M., Ueda, M., & Sasaki, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32195-6 · Cited by 464
Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., & Meisel, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-23-10291.2002 · Cited by 462
Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo
Erbayraktar, S., Grasso, G., Sfacteria, A., Xie, Q.-W., Coleman, T., Kreilgaard, M., Torup, L., Sager, T., Erbayraktar, Z., Gokmen, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031753100 · Cited by 436
Self-citationMasuda, S., Nagao, M., Takahata, K., Konishi, Y., Gallyas, F., Tabira, T., & Sasaki, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82112-3 · Cited by 421
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury
Junk, A. K., Mammis, A., Savitz, S. I., Singh, M., Roth, S., Malhotra, S., Rosenbaum, P. S., Cerami, A., Brines, M., & Rosenbaum, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152321399 · Cited by 415
Self-citationGorio, A., Gokmen, N., Erbayraktar, S., Yilmaz, O., Madaschi, L., Cichetti, C., Di Giulio, A. M., Vardar, E., Cerami, A., & Brines, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142287899 · Cited by 389
Self-citationErythropoietin and Erythropoietin Receptor in the Developing Human Central Nervous System
Juul, S. E., Anderson, D. K., Li, Y., & Christensen, R. D. (1998) · Pediatric Research · doi:10.1203/00006450-199801000-00007 · Cited by 359 · cited 1×
“By contrast, the fetal CNS expresses high levels of erythropoietin and EPOR, which indicates that erythropoietin might be important in neural developmen”
BackgroundBernaudin, M., Nedelec, A.-S., Divoux, D., MacKenzie, E. T., Petit, E., & Schumann-Bard, P. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200204000-00003 · Cited by 352
Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain
Sirén, A.-L., Knerlich, F., Poser, W., Gleiter, C. H., Brück, W., & Ehrenreich, H. (2001) · Acta Neuropathologica · doi:10.1007/s004010000297 · Cited by 349
Agnello, D., Bigini, P., Villa, P., Mennini, T., Cerami, A., Brines, M. L., & Ghezzi, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03239-0 · Cited by 334 · cited 1×
“However, in animal models that do not involve extensive apoptosis — for example, those of experimental autoimmune encephalitis and peripheral nerve injuries — erythropoietin and its analogues also have potent anti-inflammatory effect”
BackgroundSelf-citationErythropoietin as an antiapoptotic, tissue-protective cytokine
Ghezzi, P., & Brines, M. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401450 · Cited by 327
Self-citationNagai, A., Nakagawa, E., Choi, H. B., Hatori, K., Kobayashi, S., & Kim, S. U. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.4.386 · Cited by 306
Sadamoto, Y., Igase, K., Sakanaka, M., Sato, K., Otsuka, H., Sakaki, S., Masuda, S., & Sasaki, R. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9748 · Cited by 304 · cited 1×
“In pioneering in vivo studies that were elegantly performed by Sasaki and colleagues, erythropoietin was delivered intrathecally and its neuroprotective effects directly assesse”
BackgroundBeleslin-Cokic, B. B., Cokic, V. P., Yu, X., Weksler, B. B., Schechter, A. N., & Noguchi, C. T. (2004) · Blood · doi:10.1182/blood-2004-02-0744 · Cited by 289 · cited 1×
“Other studies have shown that erythropoietin also modulates nitric oxide synthesis (especially within the vasculature”
BackgroundYun, H.-Y., Dawson, V. L., & Dawson, T. M. (1996) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v10.i3-4.20 · Cited by 286
Konishi, Y., Chui, D.-H., Hirose, H., Kunishita, T., & Tabira, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)90850-m · Cited by 272 · cited 1×
“, and showed that erythropoietin has a trophic effect on central cholinergic neurons in vitro and in vivo”
BackgroundErythropoietin regulates tumour growth of human malignancies
Yasuda, Y. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg060 · Cited by 257 · cited 1×
“Third, many malignant tumours express both erythropoietin and EPOR, and tumour growth is supported by erythropoietin both in vitro and in vivo”
BackgroundErythropoietin both protects from and reverses experimental diabetic neuropathy
Bianchi, R., Buyukakilli, B., Brines, M., Savino, C., Cavaletti, G., Oggioni, N., Lauria, G., Borgna, M., Lombardi, R., Cimen, B., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307823100 · Cited by 248 · cited 1×
“and in animals with established diabetic neuropath”
Self-citationBrain Capillary Endothelial Cells Express two forms of Erythropoietin Receptor mRNA
Yamaji, R., Okada, T., Moriya, M., Naito, M., Tsuruo, T., Miyatake, K., & Nakano, Y. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0494u.x · Cited by 238 · cited 1×
“The issue of erythropoietin transport across the BBB in vivo is complicated by the fact that endothelial cells synthesize a soluble EPO”
BackgroundTan, C. C., Eckardt, K. U., Firth, J. D., & Ratcliffe, P. J. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.3.f474 · Cited by 236
Suzuki, N., Ohneda, O., Takahashi, S., Higuchi, M., Mukai, H. Y., Nakahata, T., Imagawa, S., & Yamamoto, M. (2002) · Blood · doi:10.1182/blood-2002-01-0124 · Cited by 215 · cited 1×
“However, mice that have a targeted knock-in of EPOR for the bone marrow (which allows survival) show no gross anatomical abnormalities and are fertil”
BackgroundErythropoietin: a candidate compound for neuroprotection in schizophrenia
Ehrenreich, H., Degner, D., Meller, J., Brines, M., Béhé, M., Hasselblatt, M., Woldt, H., Falkai, P., Knerlich, F., Jacob, S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001442 · Cited by 208
Self-citationThe role of erythropoietin in regulating angiogenesis
Kertesz, N., Wu, J., Chen, T. H.-P., Sucov, H. M., & Wu, H. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.08.025 · Cited by 206 · cited 1×
“It is not surprising, therefore, that erythropoietin is important in the development of the brain and the vascular syste”
BackgroundRecombinant human erythropoietin (rHuEPO) increases endothelin-1 release by endothelial cells
Carlini, R. G., Dusso, A. S., Obialo, C. I., Alvarez, U. M., & Rothstein, M. (1993) · Kidney International · doi:10.1038/ki.1993.142 · Cited by 197 · cited 1×
“Hypertension, a known advserse effect of rhEPO therapy, seems to be due, in part, to excessive endothelin productio”
BackgroundEffects of Erythropoietin on Neuronal Activity
Koshimura, K., Murakami, Y., Sohmiya, M., Tanaka, J., & Kato, Y. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722565.x · Cited by 185
Sättler, M. B., Merkler, D., Maier, K., Stadelmann, C., Ehrenreich, H., Bähr, M., & Diem, R. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401504 · Cited by 178
Grasso, G., Buemi, M., Alafaci, C., Sfacteria, A., Passalacqua, M., Sturiale, A., Calapai, G., De Vico, G., Piedimonte, G., Salpietro, F. M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082097299 · Cited by 178 · cited 1×
“This observation could explain the remarkable efficacy of erythropoietin in reversing the vascular spasm that accompanies subarachnoid haemorrhag”
Background(2001) · Neonatology · doi:10.1159/000047097 · Cited by 177
Campana, W. M., & Myers, R. R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02875.x · Cited by 169
Erythropoietin protects the in vitro blood–brain barrier against VEGF‐induced permeability
Martínez‐Estrada, O. M., Rodríguez‐Millán, E., González‐de Vicente, E., Reina, M., Vilaró, S., & Fabre, M. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02987.x · Cited by 161 · cited 1×
“fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=22339">VEGF”
Neuroprotective Effect of Erythropoietin on Hypoxic-Ischemic Brain Injury in Neonatal Rats
Kumral, A., Ozer, E., Yilmaz, O., Akhisaroglu, M., Gokmen, N., Duman, N., Ulukus, C., Genc, S., & Ozkan, H. (2003) · Neonatology · doi:10.1159/000068926 · Cited by 159
Banks, W. A., Jumbe, N. L. ‘., Farrell, C. L., Niehoff, M. L., & Heatherington, A. C. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.035 · Cited by 157
A novel endogenous erythropoietin mediated pathway prevents axonal degeneration
Keswani, S. C., Buldanlioğlu, U., Fischer, A., Reed, N., Polley, M., Hong, L. L., Zhou, C., Jack, C., Leitz, G. J., & Höke, A. (2004) · Annals of Neurology · doi:10.1002/ana.20285 · Cited by 151
Production and processing of erythropoietin receptor transcripts in brain
Chin, K., Yu, X., Beleslin‐Čokić, B. B., Liu, C., Shen, K., Mohrenweiser, H. W., & Noguchi, C. T. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00157-1 · Cited by 144 · cited 1×
“Although there might be differentially-edited transcripts of EPOR, they are not thought to be translate”
BackgroundTissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus
Chikuma, M., Masuda, S., Kobayashi, T., Nagao, M., & Sasaki, R. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.6.e1242 · Cited by 141
Juul, S. E., McPherson, R. J., Farrell, F. X., Jolliffe, L. K., Ness, D. J., & Gleason, C. A. (2003) · Neonatology · doi:10.1159/000074970 · Cited by 137 · cited 1×
“The appearance of exogenous erythropoietin in the cerebrospinal fluid (CSF) of rodents, sheep, rabbits and primates occurs with a temporal profile similar to that of erythropoietin in serum, but with a delay of 1–2 h and a peak concentration of ∼1% of the plasm”
BackgroundKilic, Ü., Kilic, E., Soliz, J., Bassetti, C. L., Gassmann, M., & Hermann, D. M. (2005) · The FASEB Journal · doi:10.1096/fj.04-2493fje · Cited by 134 · cited 1×
“Furthermore, although it has been reported that STAT is part of erythropoietin's neuroprotective signalling cascade in vitro , in vivo studies largely have not supported the involvement of STATs in erythropoietin cytoprotectio”
BackgroundGenç, Ş., Kuralay, F., Genç, K., Akhisaroğlu, M., Fadiloglu, S., Yörükoğlu, K., Fadıloğlu, M., & Güre, A. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01716-x · Cited by 132 · cited 1×
“and glutamate-induced excitotoxicity, as in models of Parkinson's diseas”
BackgroundAcute neuroprotective synergy of erythropoietin and insulin-like growth factor I
Digicaylioglu, M. H., Garden, G. A., Timberlake, S. C., Fletcher, L., & Lipton, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403172101 · Cited by 132
The β Chain of the Interleukin-3 Receptor Functionally Associates With the Erythropoietin Receptor
Jubinsky, P. T., Krijanovski, O. I., Nathan, D. G., Tavernier, J. H., & Sieff, C. A. (1997) · Blood · doi:10.1182/blood.v90.5.1867 · Cited by 131
Campana, W. M., & Myers, R. R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0857fje · Cited by 130
Non-Erythroid Functions of Erythropoietin
Gassmann, M., Heinicke, K., Soliz, J., & Ogunshola, O. O. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8997-0_22 · Cited by 128
Carlini, R. G., Obialo, C. I., & Rothstein, M. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.2.103 · Cited by 120
Wang, X., Zhu, C., Wang, X., Gerwien, J. G., Schrattenholz, A. S., Sandberg, M., Leist, M., & Blomgren, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02769.x · Cited by 118 · cited 1×
“Several studies show that asialo-erythropoietin has tissue-protective effects in rodent ischaemia and spinal cord injury models that are comparable to those of erythropoietin, but that it does not stimulate the production of erythrocyte”
BackgroundBlondeau, N., Plamondon, H., Richelme, C., Heurteaux, C., & Lazdunski, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00304-3 · Cited by 113
Nand, S., Stock, W., Godwin, J. E., & Fisher, S. G. (1996) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199605)52:1<8::aid-ajh2>3.0.co;2-z · Cited by 112
JELKMANN, W. E. B. (2002) · European Journal Of Haematology · doi:10.1034/j.1600-0609.2002.02813.x · Cited by 111
Identification of a neurotrophic sequence in erythropoietin.
Campana, W. M., Misasi, R., & O′Brien, J. S. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm.1.1.235 · Cited by 111
Springborg, J. B., Xiaodong, M., Rochat, P., Knudsen, G. M., Amtorp, O., Paulson, O. B., Juhler, M., & Olsen, N. V. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704521 · Cited by 111 · cited 1×
“Finally, erythropoietin has been shown to have beneficial effects in subarachnoid haemorrhag”
BackgroundMapping of the Active Site of Recombinant Human Erythropoietin
Elliott, S., Lorenzini, T., Chang, D., Barzilay, J., & Delorme, E. (1997) · Blood · doi:10.1182/blood.v89.2.493 · Cited by 105
Beneficial effect of erythropoietin on experimental allergic encephalomyelitis
Li, W., Maeda, Y., Yuan, R. R., Elkabes, S., Cook, S. D., & Dowling, P. C. (2004) · Annals of Neurology · doi:10.1002/ana.20274 · Cited by 102
Toll receptors: an expanding role in our understanding of human disease
Schuster, J. M., & Nelson, P. S. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.6.767 · Cited by 100
Rex, T. S., Allocca, M., Domenici, L., Surace, E. M., Maguire, A. M., Lyubarsky, A., Cellerino, A., Bennett, J., & Auricchio, A. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.027 · Cited by 99
Masuda, S., Chikuma, M., & Sasaki, R. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01186-9 · Cited by 98
The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events
Rosenzweig, M. Q., Bender, C. M., Lucke, J. P., Yasko, J. M., & Brufsky, A. (2004) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2003.06.010 · Cited by 93 · cited 1×
“For example, the use of erythropoietin to keep the haematocrit (the ratio of the volume of erythrocytes to the total volume of blood) within the normal range has shown that these prophetic adverse effects are real and problemati”
MethodErythropoietin receptor-operated Ca2+ channels: Activation by phospholipase C-γ1
Marrero, M. B., Venema, R. C., Ma, H., Ling, B. N., & Eaton, D. C. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00887.x · Cited by 88 · cited 1×
“fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=18803">PLCγ ) (Ref”
Scholz, H., Baier, W. K., Ratcliffe, P. J., Eckardt, K., Zapf, J., Kurtz, A., & Bauer, C. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.263.2.c474 · Cited by 81
Glucocorticoids: Protectors of the Brain during Innate Immune Responses
Glezer, I., & Rivest, S. (2004) · The Neuroscientist · doi:10.1177/1073858404263494 · Cited by 79
In vivo and in vitro pressor effects of erythropoietin in rats
Vaziri, N. D., Zhou, X. J., Smith, J., Oveisi, F., Baldwin, K., & Purdy, R. E. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.6.f838 · Cited by 76
Erythropoietin‐induced excessive erythrocytosis activates the tissue endothelin system in mice
Quaschning, T., Ruschitzka, F. T., Stallmach, T., Shaw, S., Morawietz, H., Göettsch, W., Hermann, M., Slowinski, T., Theuring, F., Hocher, B., et al. (2002) · The FASEB Journal · doi:10.1096/fj.02-0296fje · Cited by 72 · cited 1×
“These animals have greatly increased endothelin expression in many tissues and endothelin receptor antagonism markedly reduces the pathology shown by this mode”
BackgroundMori, M., Uchida, M., Watanabe, T., Kirito, K., Hatake, K., Ozawa, K., & Komatsu, N. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10245 · Cited by 70 · cited 1×
“In erythroid cells, the activation of MAPK results in accumulation of the anti-apoptotic protein BCL-X L by the inhibition of caspases — key mediators of apoptosis that are responsible for the degradation of BCL-X L (Ref”
BackgroundScott, C. L., Robb, L. G., Papaevangeliou, B., Mansfield, R., Nicola, N. A., & Begley, C. G. (2000) · Blood · doi:10.1182/blood.v96.4.1588 · Cited by 68 · cited 1×
“Although studies of βCR-knockout mice showed unambiguously that this subunit is not a component of the erythroid receptor that is involved in erythropoiesi”
BackgroundErythropoietin Inhibits Calcium-Induced Neurotransmitter Release from Clonal Neuronal Cells
Kawakami, M., Iwasaki, S., Sato, K., & Takahashi, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3926 · Cited by 67
Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models
Juul, S. E. (2004) · Clinics in Perinatology · doi:10.1016/j.clp.2004.03.004 · Cited by 66 · cited 1×
“Animal models for erythropoietin Comprehensive recent reviews have provided a good summary of studies that used erythropoietin as a tissue-protective agen”
MethodBlood Pressure Response to Erythropoietin Injection in Hemodialysis and Predialysis Patients
Miyashita, K., Tojo, A., Kimura, K., Goto, A., Omata, M., Nishiyama, K., & Fujita, T. (2004) · Hypertension Research · doi:10.1291/hypres.27.79 · Cited by 61 · cited 1×
“First, erythropoietin induces vascular smooth muscle contraction, which produces dose-dependent increases in blood pressure in experimental animals and human”
BackgroundEid, T., Brines, M. L., Cerami, A., Spencer, D. D., Kim, J. H., Schweitzer, J. S., Ottersen, O. P., & De Lanerolle, N. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.73 · Cited by 60
Self-citationLee, S. M., Nga, N. T. H., Park, M. H., Kim, K. S., Cho, K., Moon, D. C., Kim, H. Y., Yoon, D. Y., & Hong, J. T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.06.060 · Cited by 60 · cited 1×
“Finally, erythropoietin seems to modulate the migration and differentiation of stem cells and might, therefore, be important in tissue repair and functional recovery after injur”
BackgroundPreconditioning-mediated neuroprotection through erythropoietin?
Dawson, T. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07335-x · Cited by 59
The Polymorphonuclear Leukocyte – A New Target for Erythropoietin
Sela, S., Shurtz-Swirski, R., Sharon, R., Manaster, J., Chezar, J., Shkolnik, G., Shapiro, G., Shasha, S. M., Merchav, S., & Kristal, B. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045991 · Cited by 57 · cited 1×
“In this context, it is interesting to note that erythropoietin can apparently directly affect EPOR-expressing immune-competent cell”
BackgroundCotter, D. J., Stefanik, K., Zhang, Y., Thamer, M., Scharfstein, D. O., & Kaufman, J. S. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.05.002 · Cited by 55 · cited 1×
“A recent prospective study of patients receiving haemodialysis reported a strong correlation between erythropoietin dosing and patient mortalit”
BackgroundErythropoietin reduces the degree of arthritis caused by type II collagen in the mouse
Cuzzocrea, S., Mazzon, E., Paola, R. D., Genovese, T., Patel, N. S. A., Britti, D., Majo, M. D., Caputi, A. P., & Thiemermann, C. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20875 · Cited by 52 · cited 1×
“Erythropoietin has also recently been reported to be active in a model of rheumatoid arthriti”
BackgroundThe erythropoietin-receptor pathway modulates survival of cancer cells
Pajonk, F., Weil, A., Sommer, A. H., Suwiński, R., & Henke, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208140 · Cited by 50
Erythropoietin Potentiates Thrombus Development in a Canine Arterio-Venous Shunt Model
Wolf, R. F., Gilmore, L. S., Friese, P., Downs, T., Burstein, S. A., & Dale, G. L. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1656096 · Cited by 50
Erythropoietin stimulates testosterone production in man
Foresta, C., Mioni, R., Bordon, P., Miotto, D., Montini, G., & Varotto, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.8126153 · Cited by 49
Molecular assembly of the ternary granulocyte-macrophage colony-stimulating factor receptor complex
McClure, B. J., Hercus, T. R., Cambareri, B. A., Woodcock, J. M., Bagley, C. J., Howlett, G. J., & Lopez, A. F. (2003) · Blood · doi:10.1182/blood-2002-06-1903 · Cited by 40
Identification of erythropoietin receptors on fetal liver erythroid cells
Tojo, A., Fukamachi, H., Kasuga, M., Urabe, A., & Takaku, F. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)91131-4 · Cited by 37 · cited 1×
“Receptor-protein crosslinking studies also showed differences, with only a single associated protein of ∼45 kDa in endothelial cells, rather than the two larger ones of ∼110 and ∼95 kDa that are found in erythroid cell”
BackgroundHypoxia/Hypoglycemia-Induced Amino Acid Release Is Decreased in Vitro by Preconditioning
Johns, L., Sinclair, A. J., & Davies, J. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3443 · Cited by 33
Yamamoto, M., Koshimura, K., Sohmiya, M., Murakami, Y., & Kato, Y. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.026 · Cited by 31 · cited 1×
“In vivo microdialysis of hippocampal neurons reveals that nitric oxide production is elevated after erythropoietin stimulation — a process that requires the activation of voltage-gated calcium channel”
BackgroundUse of a Marked Erythropoietin Gene for Investigation of Its Cis-acting Elements
Ho, V., Acquaviva, A., Duh, E., & Bunn, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.10084 · Cited by 30 · cited 1×
“Furthermore, although the kidney — the main source of circulating erythropoietin — synthesizes erythropoietin mRNA only transiently in response to hypoxia, peaking within 6 h (Ref”
BackgroundErythropoietin Against Cisplatin-Induced Peripheral Neurotoxicity in Rats
Orhan, B., Yalçın, Ş., Nurlu, G., Zeybek, N. D., & Muftuoglu, S. F. (2004) · Medical Oncology · doi:10.1385/mo:21:2:197 · Cited by 28 · cited 1×
“The neuroprotective effects of erythropoietin have also been confirmed using traumatic or metabolic-toxic (for example, cisplatinu”
BackgroundErythropoietin Attenuates Post-Traumatic Injury in Organotypic Hippocampal Slices
Adembri, C., Bechi, A., Meli, E., Gramigni, E., Venturi, L., Moroni, F., Gaudio, A. R. D., & Pellegrini-Giampietro, D. E. (2004) · Journal of Neurotrauma · doi:10.1089/0897715041651079 · Cited by 21 · cited 1×
“A recent in vitro study using organotypic hippocampal slices has largely confirmed this observation, as well as showing that erythropoietin has a greater neuroprotective effect than MK-801 (dizocilpine) — an antagonist of the cytotoxic NMDA ( N -methyl- D -aspartate) recepto”
BackgroundReceptor binding of asialoerythropoietin
Dong, Y., Kung, C. K.-H., & Goldwasser, E. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240480307 · Cited by 15 · cited 1×
“However, since asialo-erythropoietin is neither metabolized nor cleared under tissue culture conditions, asialo-erythropoietin stimulates erythroid differentiation as potently as erythropoietin in vitro”
Background
Cited by
Vascular and Neurogenic Rejuvenation of the Aging Mouse Brain by Young Systemic Factors
Katsimpardi, L., Litterman, N. K., Schein, P. A., Miller, C. M., Loffredo, F. S., Wojtkiewicz, G. R., Chen, J. W., Lee, R. T., Wagers, A. J., & Rubin, L. L. (2014) · Science · doi:10.1126/science.1251141 · Cited by 1,037
ERS clinical practice guidelines on treatment of sarcoidosis
Baughman, R. P., Valeyre, D., Korsten, P., Mathioudakis, A. G., Wuyts, W. A., Wells, A., Rottoli, P., Nunes, H., Lower, E. E., Judson, M. A., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04079-2020 · Cited by 629
Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke
Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke · doi:10.1161/strokeaha.109.564872 · Cited by 605
Early management of severe traumatic brain injury
Rosenfeld, J. V., Maas, A. I., Bragge, P., Morganti-Kossmann, M. C., Manley, G. T., & Gruen, R. L. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60864-2 · Cited by 558
Metcalf, D. (2008) · Blood · doi:10.1182/blood-2007-03-079681 · Cited by 528
Metadata
- Authors
- Brines, M., & Cerami, A.
- Corresponding author
- Brines, Michael
- Venue
- Nature Reviews Neuroscience
- Published
- 2005-06-01
- Volume
- 6
- Issue
- 6
- Pages
- 484-494
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2168867226
- Cited by
- 523
- References
- 108
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 6 · 2023: 8 · 2022: 18 · 2021: 21 · 2020: 13 · 2019: 25 · 2018: 17 · 2017: 16 · 2016: 21 · 2015: 19 · 2014: 22 · 2013: 30 · 2012: 38
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Update notices
- correction (2005-08-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- www.springer.com/tdm (unspecified)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- erythropoietin, nervous system, neuroprotection, tissue damage, stroke, neuroinflammation
- MeSH terms
- Animals, Central Nervous System, Erythropoietin, Humans, Signal Transduction, Receptors, Cytokine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.